Marilyn Ader

6.5k total citations · 1 hit paper
50 papers, 4.8k citations indexed

About

Marilyn Ader is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Marilyn Ader has authored 50 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 21 papers in Physiology. Recurrent topics in Marilyn Ader's work include Metabolism, Diabetes, and Cancer (18 papers), Diabetes Management and Research (15 papers) and Pancreatic function and diabetes (15 papers). Marilyn Ader is often cited by papers focused on Metabolism, Diabetes, and Cancer (18 papers), Diabetes Management and Research (15 papers) and Pancreatic function and diabetes (15 papers). Marilyn Ader collaborates with scholars based in United States, Denmark and Belgium. Marilyn Ader's co-authors include Richard N. Bergman, Diane T. Finegood, Morvarid Kabir, Karyn J. Catalano, Yan Yang, Stella P. Kim, Donna Moore, Joyce M. Richey, Richard M. Watanabe and Jenny D. Chiu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Endocrine Reviews.

In The Last Decade

Marilyn Ader

50 papers receiving 4.7k citations

Hit Papers

Assessment of Insulin Sensitivityin Vivo* 1985 2026 1998 2012 1985 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn Ader United States 33 2.2k 1.8k 1.4k 1.1k 880 50 4.8k
Rudolf Prager Austria 38 2.5k 1.1× 1.2k 0.7× 1.2k 0.8× 1.4k 1.2× 672 0.8× 140 5.4k
C. Weyer United States 28 1.9k 0.9× 1.7k 0.9× 943 0.7× 1.2k 1.0× 1.2k 1.4× 40 4.4k
Penny Wallace United States 32 1.9k 0.9× 2.1k 1.2× 1.6k 1.2× 1.0k 0.9× 1.1k 1.3× 44 4.9k
Ole Schmitz Denmark 41 2.3k 1.0× 1.4k 0.8× 1.7k 1.2× 1.6k 1.4× 681 0.8× 136 5.2k
Graydon S. Meneilly Canada 42 3.1k 1.4× 1.5k 0.8× 1.0k 0.7× 1.4k 1.2× 603 0.7× 136 5.5k
Stefania Camastra Italy 38 1.9k 0.9× 2.1k 1.1× 1.7k 1.2× 1.9k 1.7× 968 1.1× 66 5.2k
Asimina Mitrakou Greece 39 3.5k 1.6× 1.9k 1.0× 1.7k 1.2× 1.7k 1.5× 1.2k 1.4× 91 7.0k
Antonio E. Pontiroli Italy 42 2.3k 1.0× 1.6k 0.9× 960 0.7× 2.3k 2.1× 679 0.8× 217 5.9k
Timon W. van Haeften Netherlands 31 2.4k 1.1× 1.3k 0.7× 1.7k 1.2× 1.6k 1.5× 1.2k 1.4× 79 6.2k
Ranganath Muniyappa United States 33 2.0k 0.9× 1.5k 0.9× 1.5k 1.1× 917 0.8× 1.0k 1.2× 85 6.5k

Countries citing papers authored by Marilyn Ader

Since Specialization
Citations

This map shows the geographic impact of Marilyn Ader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Ader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Ader more than expected).

Fields of papers citing papers by Marilyn Ader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Ader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Ader. The network helps show where Marilyn Ader may publish in the future.

Co-authorship network of co-authors of Marilyn Ader

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Ader. A scholar is included among the top collaborators of Marilyn Ader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Ader. Marilyn Ader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergman, Richard N., Francesca Piccinini, Morvarid Kabir, & Marilyn Ader. (2019). Novel aspects of the role of the liver in carbohydrate metabolism. Metabolism. 99. 119–125. 17 indexed citations
2.
Stefanovski, Darko, Jang H. Youn, Matthew G. Rees, et al.. (2012). Estimating Hepatic Glucokinase Activity Using a Simple Model of Lactate Kinetics. Diabetes Care. 35(5). 1015–1020. 18 indexed citations
3.
Bergman, Richard N., Stella P. Kim, Isabel Hsu, et al.. (2007). Abdominal Obesity: Role in the Pathophysiology of Metabolic Disease and Cardiovascular Risk. The American Journal of Medicine. 120(2). S3–S8. 213 indexed citations
4.
Bergman, Richard N. & Marilyn Ader. (2005). Atypical Antipsychotics and Glucose Homeostasis. The Journal of Clinical Psychiatry. 66(4). 504–514. 110 indexed citations
5.
Catalano, Karyn J., Richard N. Bergman, & Marilyn Ader. (2005). Increased Susceptibility to Insulin Resistance Associated with Abdominal Obesity in Aging Rats**. Obesity Research. 13(1). 11–20. 37 indexed citations
6.
Hamilton-Wessler, Marianthe, Marilyn Ader, Melvin K. Dea, et al.. (2002). Mode of Transcapillary Transport of Insulin and Insulin Analog NN304 in Dog Hindlimb. Diabetes. 51(3). 574–582. 41 indexed citations
7.
Ader, Marilyn. (2001). Quality indicators for health promotion programmes. Health Promotion International. 16(2). 187–195. 33 indexed citations
8.
Dea, Melvin K., G. W. van Citters, Marilyn Ader, et al.. (2000). Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.. Diabetes. 49(12). 2087–2093. 5 indexed citations
9.
Bergman, Richard N. & Marilyn Ader. (2000). Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus. Trends in Endocrinology and Metabolism. 11(9). 351–356. 479 indexed citations
10.
Hamilton-Wessler, Marianthe, Marilyn Ader, Melvin K. Dea, et al.. (1999). Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin. Diabetologia. 42(10). 1254–1263. 59 indexed citations
11.
Richey, Joyce M., Marilyn Ader, Donna Moore, & Richard N. Bergman. (1999). Angiotensin II induces insulin resistance independent of changes in interstitial insulin. American Journal of Physiology-Endocrinology and Metabolism. 277(5). E920–E926. 84 indexed citations
12.
Ader, Marilyn, et al.. (1997). Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.. Journal of Clinical Investigation. 99(6). 1187–1199. 85 indexed citations
14.
Bergman, Richard N., Richard M. Watanabe, Kerstin Rebrin, Marilyn Ader, & Garry M. Steil. (1996). Toward an Integrated Phenotype in Pre‐NIDDM. Diabetic Medicine. 13(S6). 67–77. 34 indexed citations
15.
Steil, Garry M., Marilyn Ader, Donna Moore, Kerstin Rebrin, & Richard N. Bergman. (1996). Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process.. Journal of Clinical Investigation. 97(6). 1497–1503. 113 indexed citations
16.
Bergman, Richard N., David C. Bradley, & Marilyn Ader. (1993). On Insulin Action in Vivo: The Single Gateway Hypothesis. Advances in experimental medicine and biology. 334. 181–198. 19 indexed citations
18.
Bergman, Richard N., et al.. (1989). Assessment of insulin sensitivity in vivo: A critical review. Diabetes/Metabolism Reviews. 5(5). 411–429. 106 indexed citations
19.
Youn, Jang H., Marilyn Ader, & Richard N. Bergman. (1989). Glucose phosphorylation is not rate limiting for accumulation of glycogen from glucose in perfused livers from fasted rats. Journal of Biological Chemistry. 264(1). 168–172. 8 indexed citations
20.
Bergman, Richard N., Marilyn Ader, Diane T. Finegood, & Giovanni Pacini. (1984). Extrapancreatic effect of somatostatin infusion to increase glucose clearance. American Journal of Physiology-Endocrinology and Metabolism. 247(3). E370–E379. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026